Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Emerald Health Therapeutics Inc EMHTF

Emerald is committed to creating new consumer experiences with distinct recreational, medical and wellness-oriented cannabis products with an emphasis on innovation and production excellence.

OTCQB:EMHTF - Post Discussion

Emerald Health Therapeutics Inc > last 2.05...shes ready
View:
Post by laptop555 on Jul 25, 2019 12:15pm

last 2.05...shes ready

$2.23 to 2.27 target
Comment by MarketBS on Jul 26, 2019 10:42am
Wow, what a target! lol..... from $9 to a target of just over $2 all that’s happening now are day traders buying on the dips and selling on a slight move up... then back down it goes so sad, it gets a little bump and everyone’s excited. read my posts, this is exactly what I said happens. this could go to $3 and it’s still a long way from being decent. get I back over $5 then it might get a ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities